FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. ALAR
3. SPY
4. PBA
5. CCH:LN

August 10, 2016 12:50 PM EDT

Price: $0.44 +4.76%

Overall Analyst Rating:
SELL (= Flat)

Revenue Growth %: +13.3%

Below is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:

FDA, Insiders' Blog

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!